日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition

活化 EGFR 中的不稳定 Y891D 突变会削弱对激酶抑制的敏感性

Daniel S Lenchner #, Zaritza O Petrova #, Lisa Hunihan, Kumar D Ashtekar, Zenta Walther, Frederick H Wilson

RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition

RASGRF1 融合激活致癌 RAS 信号并赋予对 MEK 抑制的敏感性

Lisa Hunihan, Dejian Zhao, Heather Lazowski, Man Li, Yuping Qian, Laura Abriola, Yulia V Surovtseva, Viswanathan Muthusamy, Lynn T Tanoue, Bonnie E Gould Rothberg, Kurt A Schalper, Roy S Herbst, Frederick H Wilson

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies

针对 MAPT 的锁定核酸反义寡核苷酸治疗 tauopathies 的鉴别和表征

Amy Easton, Marianne L Jensen, Congwei Wang, Peter H Hagedorn, Yuwen Li, Michael Weed, Jere E Meredith, Valerie Guss, Kelli Jones, Martin Gill, Carol Krause, Jeffrey M Brown, Lisa Hunihan, Joanne Natale, Alda Fernandes, Yifeng Lu, Joe Polino, Mark Bookbinder, Greg Cadelina, Yulia Benitex, Ramola San